Versant Ventures
Mehmet joined Versant in March 2022 as a Senior Associate and was promoted to Principal in October 2022. He is based in San Diego and works on investments and company creation opportunities primarily on the West Coast.
Prior to joining Versant, Mehmet worked at Rheos Medicines where he most recently focused on business development and corporate strategy efforts. He initially joined Rheos Medicines as a discovery scientist where he helped build the metabolomics platform that enabled their early program development.
Mehmet completed his PhD in Bioengineering at the University of California, San Diego.
This person is not in the org chart
This person is not in any offices
Versant Ventures
1 followers
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $2.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs.